GlobeNewswire: EndoLogic Contains the last 10 of 4 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T23:18:25ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2018/05/15/1502493/0/en/EndoLogic-Announces-FDA-Accepts-Cardiac-Safety-Trial-for-Renzapride-in-Patients-with-Gastroparesis.html?f=22&fvtc=4&fvtv=31003EndoLogic Announces FDA Accepts Cardiac Safety Trial for Renzapride in Patients with Gastroparesis2018-05-15T12:00:00Z<![CDATA[Study demonstrates no evidence of QTc prolongation]]>https://www.globenewswire.com/news-release/2017/08/09/1082521/0/en/EndoLogic-Announces-Feedback-from-Positive-FDA-Meeting-for-Renzapride-in-Diabetic-Gastroparesis.html?f=22&fvtc=4&fvtv=31003EndoLogic Announces Feedback from Positive FDA Meeting for Renzapride in Diabetic Gastroparesis2017-08-09T12:00:00Z<![CDATA[FDA pre-IND meeting minutes describe steps required for new drug application (NDA) submission]]>https://www.globenewswire.com/news-release/2017/05/03/977037/0/en/EndoLogic-Announces-Scheduling-of-pre-IND-Meeting-with-FDA-to-Discuss-Renzapride-in-Diabetic-Gastroparesis.html?f=22&fvtc=4&fvtv=31003EndoLogic Announces Scheduling of pre-IND Meeting with FDA to Discuss Renzapride in Diabetic Gastroparesis2017-05-03T12:30:00Z<![CDATA[Meeting scheduled on July 25, 2017, will address proposed renzapride Phase 2 trial and acceptability of toxicity and safety evaluations that had been previously submitted to the FDA Meeting scheduled on July 25, 2017, will address proposed renzapride Phase 2 trial and acceptability of toxicity and safety evaluations that had been previously submitted to the FDA]]>https://www.globenewswire.com/news-release/2017/01/03/902783/0/en/EndoLogic-Acquires-Renzapride-from-Alizyme-plc.html?f=22&fvtc=4&fvtv=31003EndoLogic Acquires Renzapride from Alizyme, plc2017-01-03T13:00:00Z<![CDATA[Clinical-stage asset to be developed for gastroparesis, a poorly-met medical need Clinical-stage asset to be developed for gastroparesis, a poorly-met medical need]]>